Ponatinib Shows Promise in Pediatric/Adolescent ALL Patients
Ponatinib (Iclusig) induced a complete remission in one pediatric/adolescent patient with Philadelphia chromosome-positive acute lymphoblastic leukemia, and demonstrated promising clinical activity in another.
Source: OncLive